Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer
-
Published:2024-08
Issue:
Volume:120
Page:208-220
-
ISSN:0889-1591
-
Container-title:Brain, Behavior, and Immunity
-
language:en
-
Short-container-title:Brain, Behavior, and Immunity
Author:
Otto-Dobos L.D.ORCID, Grant C.V., Lahoud A.A., Wilcox O.R., Strehle L.D., Loman B.R., Adarkwah Yiadom S., Seng M.M., Halloy N.R., Russart K.L.G., Carpenter K.M., Dawson E., Sardesai S.D., Williams N.O., Gatti-Mays M.E., Stover D.G., Sudheendra P.K., Wesolowski R., Kiecolt-Glaser J.K., Bailey M.T., Andridge R.R., Pyter L.M.ORCID
Reference72 articles.
1. Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy;Aarnoutse;NPJ Breast Cancer,2022 2. The Gut Microbiota and Inflammation: An Overview;Al Bander;Int J Environ Res Public Health,2020 3. Hopkins Verbal Learning Test – Revised: Normative Data and Analysis of Inter-Form and Test-Retest Reliability;Benedict;Clin Neuropsychol,1998 4. Benton, A.L., Hamsher, K., 1976. Multilingual aphasia examination (2nd ed.). AJA Associates. 5. Impacts of breast cancer and chemotherapy on gut microbiome, cognitive functioning, and mood relative to healthy controls;Bilenduke;Sci Rep,2022
|
|